Goldman Sachs Group Inc Bridge Bio Pharma, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,051,973 shares of BBIO stock, worth $57.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,051,973
Previous 2,298,039 10.71%
Holding current value
$57.4 Million
Previous $58.2 Million 10.25%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$23.91 - $31.3 $5.88 Million - $7.7 Million
-246,066 Reduced 10.71%
2,051,973 $52.2 Million
Q2 2024

Aug 13, 2024
BUY
$23.0 - $31.04 $15.5 Million - $20.9 Million
672,280 Added 41.35%
2,298,039 $58.2 Million
Q1 2024

May 15, 2024
SELL
$27.35 - $40.45 $44.9 Million - $66.4 Million
-1,640,876 Reduced 50.23%
1,625,759 $50.3 Million
Q4 2023

Feb 13, 2024
BUY
$24.02 - $43.89 $44.2 Million - $80.8 Million
1,841,478 Added 129.21%
3,266,635 $132 Million
Q3 2023

May 14, 2024
SELL
$16.89 - $35.01 $31.1 Million - $64.5 Million
-1,841,478 Reduced 56.37%
1,425,157 $37.6 Million
Q3 2023

Nov 14, 2023
BUY
$16.89 - $35.01 $6.75 Million - $14 Million
399,689 Added 38.98%
1,425,157 $37.6 Million
Q2 2023

May 14, 2024
BUY
$13.29 - $18.01 $667,649 - $904,768
50,237 Added 5.15%
1,025,468 $17.6 Million
Q2 2023

Aug 14, 2023
BUY
$13.29 - $18.01 $667,649 - $904,768
50,237 Added 5.15%
1,025,468 $17.6 Million
Q1 2023

May 14, 2024
SELL
$7.17 - $18.55 $2.73 Million - $7.05 Million
-380,065 Reduced 28.04%
975,231 $16.2 Million
Q1 2023

May 11, 2023
SELL
$7.17 - $18.55 $2.73 Million - $7.05 Million
-380,065 Reduced 28.04%
975,231 $16.2 Million
Q4 2022

May 14, 2024
BUY
$6.74 - $11.52 $977,879 - $1.67 Million
145,086 Added 11.99%
1,355,296 $10.3 Million
Q4 2022

Feb 13, 2023
BUY
$6.74 - $11.52 $977,879 - $1.67 Million
145,086 Added 11.99%
1,355,296 $10.3 Million
Q3 2022

May 14, 2024
BUY
$7.94 - $12.36 $2.02 Million - $3.15 Million
254,698 Added 26.66%
1,210,210 $12 Million
Q3 2022

Nov 10, 2022
BUY
$7.94 - $12.36 $2.02 Million - $3.15 Million
254,698 Added 26.66%
1,210,210 $12 Million
Q2 2022

May 14, 2024
SELL
$5.21 - $12.14 $12 Million - $28.1 Million
-2,311,123 Reduced 70.75%
955,512 $8.68 Million
Q2 2022

Aug 15, 2022
BUY
$5.21 - $12.14 $1.21 Million - $2.83 Million
232,765 Added 32.21%
955,512 $8.68 Million
Q1 2022

May 16, 2022
BUY
$7.34 - $17.16 $72,218 - $168,837
9,839 Added 1.38%
722,747 $7.34 Million
Q4 2021

Feb 14, 2022
BUY
$11.38 - $53.41 $1.07 Million - $5.04 Million
94,369 Added 15.26%
712,908 $11.9 Million
Q3 2021

Nov 10, 2021
BUY
$46.87 - $64.24 $29 Million - $39.7 Million
618,539 New
618,539 $29 Million

Others Institutions Holding BBIO

# of Institutions
290
Shares Held
170M
Call Options Held
10.4M
Put Options Held
2.37M
View Full List

About BridgeBio Pharma, Inc.

BBIO Quotes by TradingView
  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.15B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email